FDA issues safety alert about PPIs and C. diff

The FDA announced that proton-pump inhibitors used to treat heartburn and acid reflux can increase the risk of diarrhea associated with Clostridium difficile, and said it was working with drugmakers on label changes for their PPI products. C. diff disease can be difficult to treat and can lead to serious complications; it's been a growing problem in hospitals for the past several years. Release | Report